Status:
COMPLETED
Video Consultation to Reduce Drug Interactions Among Patients Initiating Oral Anti-Cancer Drugs
Lead Sponsor:
Columbia University
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a non-randomized prospective pilot intervention study to assess the feasibility of a onetime pharmacist-led video consultation for medication review and patient education among patients initia...
Detailed Description
In this study, the investigator will be evaluating a 30-minute pharmacist-led video consultation to provide education about patients new oral anti-cancer drug (OACD) and help identify and manage poten...
Eligibility Criteria
Inclusion
- Adults age ≥18 years
- Patients must have access to a smartphone, tablet, or computer to facilitate a video visit, or be willing to come into the hospital to borrow a tablet for the visit
- Patients must have received a prescription for a new oral anti-cancer drug within 4 weeks of enrollment, not administered as part of a clinical trial
- Patients must take at least three prescribed, standing oral medications in addition to their newly prescribed anti-cancer drug
Exclusion
- Patients who do not speak English or Spanish
- Patients without cognitive capacity to give informed consent for participation
- Patients uncomfortable with using video-based technology
Key Trial Info
Start Date :
June 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05299671
Start Date
June 22 2021
End Date
May 5 2023
Last Update
February 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032